US 11319286
Heterocyclic compound and application thereof
granted A61KA61K31/40A61K31/4025
Quick answer
US patent 11319286 (Heterocyclic compound and application thereof) held by Takeda Pharmaceutical Company Limited expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue May 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/40, A61K31/4025, A61K31/506, A61K9/2018